Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Sell
3,425
-2,733
-44% -$234K 0.07% 402
2025
Q4
$527K Buy
+6,158
New +$515K 0.13% 259
2024
Q4
Sell
-4,500
Closed -$652K 623
2024
Q3
$652K Buy
+4,500
New +$614K 0.25% 124
2023
Q3
Sell
-6,284
Closed -$707K 430
2023
Q2
$707K Buy
+6,284
New +$749K 0.38% 57
2022
Q1
Sell
-8,049
Closed -$1.03M 303
2021
Q4
$1.03M Buy
+8,049
New +$1.24M 1% 6
2021
Q3
Sell
-5,178
Closed -$603K 407
2021
Q2
$603K Buy
+5,178
New +$510K 0.23% 131

Other funds holding CROX

Bridgefront Capital's CROX Position: Q1 2026 in Review

Bridgefront Capital reduced its Crocs (CROX) stake by 44% in Q1 2026, selling an estimated $234K and leaving 3,425 shares worth $284K. The position accounts for 0.07% of the portfolio, ranked #402.

Bridgefront Capital first reported a position in CROX in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.03M in Q4 2021. 456 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

  • Bridgefront Capital held 3,425 shares of Crocs worth $284K as of Q1 2026.
  • Bridgefront Capital sold 2,733 Crocs shares in Q1 2026, an estimated $234K.
  • Crocs made up 0.07% of Bridgefront Capital's portfolio in Q1 2026, its #402 holding.
  • Bridgefront Capital first reported a position in Crocs in Q2 2021 and has held it in 6 quarters since.
  • Bridgefront Capital's Crocs position peaked at $1.03M in Q4 2021.
  • 456 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.